OA06416A - Procédé de production d'un ADN comprenant le genome du virus de l'hépatite B et vecteur le comportant. - Google Patents

Procédé de production d'un ADN comprenant le genome du virus de l'hépatite B et vecteur le comportant.

Info

Publication number
OA06416A
OA06416A OA56977A OA56977A OA06416A OA 06416 A OA06416 A OA 06416A OA 56977 A OA56977 A OA 56977A OA 56977 A OA56977 A OA 56977A OA 06416 A OA06416 A OA 06416A
Authority
OA
OAPI
Prior art keywords
hepatitis
genome
virus
dna
vector
Prior art date
Application number
OA56977A
Other languages
English (en)
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Publication of OA06416A publication Critical patent/OA06416A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
OA56977A 1978-12-18 1979-12-18 Procédé de production d'un ADN comprenant le genome du virus de l'hépatite B et vecteur le comportant. OA06416A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7835588A FR2444713A1 (fr) 1978-12-18 1978-12-18 Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant

Publications (1)

Publication Number Publication Date
OA06416A true OA06416A (fr) 1981-09-30

Family

ID=9216265

Family Applications (1)

Application Number Title Priority Date Filing Date
OA56977A OA06416A (fr) 1978-12-18 1979-12-18 Procédé de production d'un ADN comprenant le genome du virus de l'hépatite B et vecteur le comportant.

Country Status (6)

Country Link
BE (1) BE880670A (fr)
CH (1) CH646456A5 (fr)
DE (1) DE2950995A1 (fr)
FR (1) FR2444713A1 (fr)
GB (1) GB2034323B (fr)
OA (1) OA06416A (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
EP0182442B2 (fr) * 1978-12-22 1996-04-03 Biogen, Inc. Molécules de l'ADN recombinant et procédé pour leur production
LU88257I2 (fr) * 1978-12-22 1994-02-03
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
IE52036B1 (en) * 1979-05-24 1987-05-27 Univ California Non-passageable viruses
US5196194A (en) * 1979-05-24 1993-03-23 The Regents Of The University Of California Vaccines containing Hepatitis B S-protein
US6835557B1 (en) 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
DE3176404D1 (en) * 1980-04-22 1987-10-08 Pasteur Institut Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US5145782A (en) * 1980-12-08 1992-09-08 The Regents Of The University Of California DNA expression vector suitable for direct expression of a foreign gene
US4446237A (en) * 1981-03-27 1984-05-01 Life Technologies, Inc. Method for detection of a suspect viral deoxyribonucleic acid in an acellular biological fluid
EP0062286A1 (fr) * 1981-03-31 1982-10-13 Albert Einstein College Of Medicine Of Yeshiva University Test diagnostique du virus de l'hépatite B
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
US4769238A (en) 1981-08-04 1988-09-06 The Regents Of The University Of California Synthesis of human virus antigens by yeast
ZW18282A1 (en) 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
US4803164A (en) * 1981-08-31 1989-02-07 Genentech, Inc. Preparation of hepatitis b surface antigen in yeast
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
FI63596C (fi) * 1981-10-16 1983-07-11 Orion Yhtymae Oy Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
US4480040A (en) * 1981-12-03 1984-10-30 The United States Of America As Represented By The Secretary Of Agriculture Sensitive and rapid diagnosis of viroid diseases and viruses
JPS5931799A (ja) * 1982-08-16 1984-02-20 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えプラスミド
USRE35491E (en) * 1982-11-04 1997-04-08 The Regents Of The University Of California Methods and compositions for detecting human tumors
US4699877A (en) * 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
US4820642A (en) * 1983-04-04 1989-04-11 The Regents Of The University Of California Amplified expression vector
FR2560995B1 (fr) * 1984-03-07 1988-02-19 Pasteur Institut Reactifs et necessaires pour le dosage quantitatif d'un acide nucleique viral dans un milieu biologique et procede de dosage de cet acide nucleique viral
US5780036A (en) * 1991-08-26 1998-07-14 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
US6607727B1 (en) 1991-08-26 2003-08-19 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
DE69231693T2 (de) * 1991-12-23 2001-05-31 Bayer Ag Hbv amplifizierungssonden zur verwendung in hybridisierungssandwichassay in der lösungsphase
US6235288B1 (en) 1992-08-26 2001-05-22 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
JP2003502033A (ja) 1999-06-16 2003-01-21 アイコス コーポレイション ヒトポリ（ａｄｐ−リボース）ポリアミラーゼ２材料および方法
US7405276B2 (en) 2000-11-01 2008-07-29 Elusys Therapeutics, Inc. Method of producing bispecific molecules by protein trans-splicing
CA2605701C (fr) 2005-04-29 2015-12-08 Rockefeller University Micro-arn humains et procedes d'inhibition de ceux-ci
EP1928492B1 (fr) 2005-09-01 2011-02-23 Celgene Corporation Utilisations immunologiques de composes immunomodulateurs pour vaccins et traitement anti-infectieux de maladies
JP2010531878A (ja) 2007-06-27 2010-09-30 マリン ポリマー テクノロジーズ，インコーポレーテッド ＩＬ‐１５とＩＬ‐１５Ｒαとの複合体及びその使用
EP2324044A4 (fr) 2008-08-04 2012-04-25 Univ Miami Sting (stimulateur de gènes d interféron), un régulateur de réponses immunitaires innées
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
WO2010085660A2 (fr) 2009-01-23 2010-07-29 Roger Williams Hospital Vecteurs viraux codant pour de multiples polypeptides non viraux très homologues et leur utilisation
WO2011091435A2 (fr) 2010-01-25 2011-07-28 Mount Sinai School Of Medicine Méthodes de traitement de maladies hépatiques
WO2012151272A2 (fr) 2011-05-02 2012-11-08 Tremrx, Inc. Vaccination avec des lymphocytes t à l'aide de vecteurs viraux par rupture épidermique mécanique
CA2863600A1 (fr) 2012-02-16 2013-08-22 The Penn State Research Foundation Modulateurs de l'acyl-coa lysocardiolipine acyltransferase 1 (alcat1) et leurs utilisations
WO2014066527A2 (fr) 2012-10-24 2014-05-01 Admune Therapeutics Llc Formes d'il-15r alpha, cellules exprimant des formes d'il-15r alpha, et utilisations thérapeutiques d'il-15r alpha et de complexes il-15/il-15r alpha
WO2016018920A1 (fr) 2014-07-29 2016-02-04 Admune Therapeutics Llc Régimes d'escalade de dose d'hétérodimère il-15 et il-15 r-alpha pour traiter des troubles
US11370823B2 (en) 2014-10-29 2022-06-28 Massachusetts Eye And Ear Infirmary Efficient delivery of therapeutic molecules to cells of the inner ear
WO2016069912A1 (fr) 2014-10-29 2016-05-06 Massachusetts Eye And Ear Infirmary Admnistration efficace de molécules thérapeutiques in vitro et in vivo
US20220118077A1 (en) 2018-09-11 2022-04-21 Shanghai Public Health Clinical Center Immunogen for broad-spectrum influenza vaccine and application thereof
US11786592B2 (en) 2021-05-19 2023-10-17 The University Of Hong Kong Compositions of cardiolipin adjuvants and methods of use thereof
WO2023077147A2 (fr) 2021-11-01 2023-05-04 Pellis Therapeutics, Inc. Vaccins à lymphocytes t pour patients présentant une immunité humorale réduite
WO2023220283A1 (fr) 2022-05-12 2023-11-16 Pellis Therapeutics, Inc. Adjuvant de poxvirus pour vaccination par lymphocytes t

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1521032A (en) * 1974-08-08 1978-08-09 Ici Ltd Biological treatment
DE2712615A1 (de) * 1977-03-18 1978-09-21 Max Planck Gesellschaft Verfahren zur herstellung von filamentoesen phagen als vektor fuer synthetische rekombinate

Also Published As

Publication number Publication date
DE2950995C2 (fr) 1991-05-02
CH646456A5 (fr) 1984-11-30
FR2444713A1 (fr) 1980-07-18
BE880670A (fr) 1980-06-18
GB2034323B (en) 1983-01-12
FR2444713B1 (fr) 1981-02-06
GB2034323A (en) 1980-06-04
DE2950995A1 (de) 1980-07-24

Similar Documents

Publication Publication Date Title
OA06416A (fr) Procédé de production d'un ADN comprenant le genome du virus de l'hépatite B et vecteur le comportant.
GB2070621B (en) Nucleotidic sequence coding the surface antigen of the hepatitis b virus vector containing said nucleotidic sequence process allowing the obtention thereof and antigen obtained thereby
YU140380A (en) Process for obtaining dna fragment of hepatitis b virus
IT8267522A0 (it) Procedimento per la produzione di dna complementare rappresentante sequenze virali di rna mediante metodi del dna ricombinante prodotti relativi e loro usi
IT7920867A0 (it) Procedimento di produzione di percettori di gas d'ossigeno.
ES449670A1 (es) Un metodo de reparacionnconcentracion de virus de hepatitis de mezclas de material biologico.
KR870007282A (ko) 효모에서 b형 간염 바이러스 단백질을 제조하는 방법
NL7903927A (nl) Vinyltegel en werkwijze voor de vervaardiging daarvan.
BE827439A (fr) Procede pour l'obtention catalytique de pyridines a partir d'alcynes et de nitriles
OA06823A (fr) Procédé d'élaboration d'acier inoxydable.
OA06920A (fr) Halogénures d'ammonium spiro-quartenaire, leur procédé de préparation et leur utilisation dans un procédé de production de N-(2-pyrimidinyl) pipérazinyl-alkylazospiro-alcanédiones.
RO72609A (fr) P9ocede de preparation des ether et thioethers de 1-aryle-2-imidazolyle)-alkyle
PT73021A (en) Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens
EP0182442A3 (en) Recombinant DNA molecules and their method of production.
ATA147379A (de) Vinylhalogenidpolymerisationsverfahren
JPS5550892A (en) Protein production * modified dna and vector applicable to said method
IT8141656A0 (it) Processo industriale per laproduzione di tessuti jacquardtubolari e prodotto cosi' ottenuto.
GB2079288B (en) Dna sequences recombinat dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens
OA05568A (fr) Procédé chimique d'enrichissement isotopique de l'uranium.
NL7903866A (nl) Warmte-geisoleerde buis en werkwijze voor de vervaardiging daarvan.
AT387392B (de) Verfahren zur herstellung von 1alpha, 3betadihydroxy-delta 5-steroiden
FR2606281B1 (fr) Antigene du virus de l'hepatite b et procede pour sa production
FR2464269B1 (fr) Sequence nucleotidique codant l'antigene de surface du virus de l'hepatite b, procede permettant son obtention et antigene obtenu
MX5789E (es) Proceso mejorado de polimerizacion en suspension
EP0119259A4 (fr) Virus de l'hepatite non a, non b, procedes d'identification, de purification, de caracterisation, de diagnostic et d'immunisation.